Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.750 -0.150 (-2.17%)

Streaming Delayed Price Updated: 9:50 AM EST, Dec 30, 2025 Add to My Watchlist

Price and Volume

Volume	1,169
Open	6.750
Bid (Size)	6.750 (800)
Ask (Size)	6.850 (200)
Prev. Close	6.900
Today's Range	6.750 - 6.750
52wk Range	5.592 - 11.99
Shares Outstanding	13,415,066
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗

December 15, 2025

Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins.

Via Chartmill

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

December 15, 2025

Via ACCESS Newswire

Performance

YTD	-17.7%	-17.7%
1 Month	+12.5%	+12.5%
3 Month	+5.8%	+5.8%
6 Month	-8.4%	-8.4%
1 Year	-21.7%	-21.7%

More News

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

December 08, 2025

Via ACCESS Newswire

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

September 15, 2025

Via ACCESS Newswire

Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗

September 15, 2025

Via Chartmill

Insights Ahead: Champions Oncology's Quarterly Earnings ↗

September 12, 2025

Via Benzinga

Champions Oncology Reports Record Annual Revenue of $57 Million

July 23, 2025

Via ACCESS Newswire

Earnings Scheduled For July 23, 2025 ↗

July 23, 2025

Via Benzinga

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

September 15, 2025

Via ACCESS Newswire

Earnings Scheduled For September 15, 2025 ↗

September 15, 2025

Via Benzinga

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

September 10, 2025

Via ACCESS Newswire

4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗

September 03, 2025

Via Benzinga

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

July 21, 2025

Via ACCESS Newswire

Recap: Champions Oncology Q2 Earnings ↗

December 11, 2024

Via Benzinga

Champions Oncology Announces Appointment of New CEO

July 18, 2025

Via ACCESS Newswire

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

July 08, 2025

Via ACCESS Newswire

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

April 28, 2025

Via ACCESS Newswire

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

April 24, 2025

Via ACCESS Newswire

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

March 11, 2025

Via ACCESS Newswire

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

March 06, 2025

Via ACCESS Newswire

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

February 18, 2025

Via ACCESS Newswire

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗

January 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 17, 2025

Via Benzinga

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

January 08, 2025

Via ACCESSWIRE

Frequently Asked Questions

Is Champions Oncology, Inc. - Common Stock publicly traded?

Yes, Champions Oncology, Inc. - Common Stock is publicly traded.

What exchange does Champions Oncology, Inc. - Common Stock trade on?

Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Champions Oncology, Inc. - Common Stock?

The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market

What is the current price of Champions Oncology, Inc. - Common Stock?

The current price of Champions Oncology, Inc. - Common Stock is 6.750

When was Champions Oncology, Inc. - Common Stock last traded?

The last trade of Champions Oncology, Inc. - Common Stock was at 12/30/25 09:50 AM ET

What is the market capitalization of Champions Oncology, Inc. - Common Stock?

The market capitalization of Champions Oncology, Inc. - Common Stock is 90.55M

How many shares of Champions Oncology, Inc. - Common Stock are outstanding?

Champions Oncology, Inc. - Common Stock has 91M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.